Optimal prosthetic graft design for small diameter vascular grafts

Vascular

Volumn 15, Issue 6, 2007, Pages 356-360

  Nishibe, Toshiya ^a   Kondo, Yuka ^a   Muto, Akihito ^b   Dardik, Alan ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Expanded polytetrafluoroethylene grafts; Tissue engineering; Vascular grafts

Indexed keywords

POLITEF;

BIOCHEMICAL COMPOSITION; BLOOD VESSEL GRAFT; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; PROSTHESIS; REVIEW; STEM CELL; TISSUE ENGINEERING; VASCULAR TISSUE; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; HUMANS; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; TISSUE ENGINEERING;

EID: 37349115503     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2007.00053     Document Type: Review

References (34)

1. Voorhees AB Jr, Jaretzki A, Blakemore AH. The use of tubes constructed of Vinyon N cloth in bridging arterial defects. Ann Surg 1952;135:332.
2. Creech O Jr, Detering RA Jr, Edwards S, et al. Vascular prostheses, report of the Committee for the Study of Vascular Prostheses of the Society for Vascular Surgery. Surgery 1957;41:62.
3. Plumkett RJ, inventor. US patent 2,230,654. 1941.
4. Oga S, inventor. Japanese patent 42-13560 (67/13560). 1967.
5. Matsumoto H, Hasegawa T, Fuse K, et al. A new vascular prosthesis for a small caliber artery. Surgery 1973;74:519-23.
6. Xue L, Greisler HP. Prosthetic grafts In: Rutherford RB, editor. Vascular surgery. 6th ed. Philadelphia: Elsevier; 2005. p. 723-40.
7. Campbell CD, Goldfarb D, Roe R. A small arterial substitute: expanded microporous polytetrafluoroethylene: patency versus porosity. Ann Surg 1975;182:138-43.
8. Branson DF, Picha GJ, Despers J. Expanded polytetrafluoroethylene as a microvascular graft: a study of four fibril lengths. Plast Reconstr Surg 1985;76:754-63.
9. Golden MA, Hanson SR, Kirkman TR, et al. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg 1990;11:838-45.
10. Hirabayashi K, Saitoh E, Ijima H, et al. Influence of fibril length upon ePTFE graft healing and host modification of the implant. J Biomed Mater Res 1992;26:1433-47.
11. Nagae T, Tsuchida H, Peng SK, et al. Composite porosity of expanded polytetrafluoroethylene vascular prosthesis. Cardiovasc Surg 1995;3:479-84.
12. Hazama K, Miura H, Shimada T, et al. Relationship between fibril length and tissue ingrowth in the healing of expanded polytetrafluoroethylene grafts. Surg Today 2004;34:685-9.
13. Wesolowski SA, Fries CC, Karlson KE. Porosity: primary determinant of ultimate fate of synthetic vascular grafts. Surgery 1961;50:91-8.
14. Anderson JM. Inflammatory response to implants. Am Soc Artif Intern Org 1988;11:101-7.
15. Seeger JM, Klingmann N. Improved endothelialization of prosthetic grafts by surface modification with fibronectin. J Vasc Surg 1988;8:476-82.
16. Mosher DF. Physiology of fibronectin. Annu Rev Med 1984;35:561-75.
17. Gounty P, Hocquet-Cheynel C, Mantin-Mondiere C, et al. Incorporation of fibronectin-impregnated vascular prostheses in the pig. J Cardiovasc Surg 1995;36:573-80.
18. Nishibe T, Okuda Y, Kumada T, et al. Enhanced graft healing of high porosity expanded polytetrafluoroethylene grafts by covalent bonding of fibronectin. Surg Today 2000;30:426-31.
19. Nishibe T, O'Donnel S, Pikoulis E, et al. Effects of fibronectin bonding on healing of high porosity expanded polytetrafluoroethylene grafts in pigs. J Cardiovasc Surg 2001;42:667-73.
20. Greisler HP, Cziperle DJ, Kim DU, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 1992;112:244-55.
21. Gray JL, Kang SS, Zenni GC, et al. FGF-1 affixation stimulates ePTFE endothelialization without hyperplasia. J Surg Res 1994;57:596-612.
22. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autigenous endothelium. Surgery 1978;84:498-504.
23. Graham LM, Stanley JC, Burkel WE. Improved patency of endothelial-cell-seeded, long, knitted Dacron and ePTFE vascular prostheses. ASAIO J 1985;8:65-8.
24. Dardik A, Liu A, Ballermann BJ. Chronic in vitro shear stress stimulates endothelial cell retention on prosthetic vascular grafts, reducing subsequent in vivo neointimal thickness. J Vasc Surg 1999;29:157-67.
25. Herring MB, Compton RS, LeGrand DR, et al. Endothelial seeding of polytetrafluoroethylene popliteal bypasses. A preliminary report. J Vasc Surg 1987;6:114-8.
26. Zilla P, Deutsch M, Meinhart J, et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg 1994;19:540-8.
27. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 1996;2:90-3.
28. Bhattacharya V, McSweeney PA, Shi Q, et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000;95:581-5.
29. Williams SK, Kleinert LB, Rose D, Mckenney S. Origin of endothelial cells that line expanded polytetrafluoroethlene vascular grafts sodded with cells from microvascularized fat. J Vasc Surg 1994;19:594-604.
30. Katz AJ, Tholpady A, Tholpady SS, et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005;23:412-23.
31. DiMuzio P, Fischer L, McIlhenny S, et al. Development of a tissue-engineered bypass graft seeded with stem cells. Vascular 2006;14:338-42.
32. Planat-Benard V, Silvestre J-S, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;110:349-55.
33. Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 2005;103:12167-72.
34. Shin'oka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-8.